Sean McCutcheon
Stock Analyst at Raymond James
(0.20)
# 4,288
Out of 4,962 analysts
9
Total ratings
22.22%
Success rate
-27.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $4.38 | +173.97% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $23.01 | +182.49% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $3.02 | +198.01% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.87 | +283.28% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $4.30 | +434.88% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $8.01 | +399.38% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $37.01 | +89.14% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $34.60 | +148.55% | 1 | Mar 13, 2024 |
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $4.38
Upside: +173.97%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $23.01
Upside: +182.49%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $3.02
Upside: +198.01%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.87
Upside: +283.28%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $4.30
Upside: +434.88%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $8.01
Upside: +399.38%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $37.01
Upside: +89.14%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $34.60
Upside: +148.55%